DNA Day 2025: Over 150,000 Genomes & One Collaborative Vision
By: Dr. Meredith McLaren, CEO, CGEn Today is DNA Day, celebrated internationally to commemorate the 1953 discovery of the DNA […]
By: Dr. Meredith McLaren, CEO, CGEn Today is DNA Day, celebrated internationally to commemorate the 1953 discovery of the DNA […]
CGEn will generate high-quality genomes to help accelerate precision health solutions for Canadians March 5, 2025 – Today in Ottawa,
CGEn is thrilled to welcome Dr. Vardit Ravitsky to our Board of Directors! President and CEO of The Hastings Center,
CGEn is excited to announce the addition of new members to our Board of Directors and Scientific Advisory Board (SAB),
Meredith McLaren named CEO of CGEn The Board of Directors and Executive Committee of CGEn, Canada’s national platform for genome
CGEn sat down with Mark Engstrom, Associate Professor at the University of Toronto and Deputy Director, Collections & Research at
Unleashing the Potential: The Transformative Role of Artificial Intelligence in Precision Medicine By: Shantala Hari Dass From left to right:
Diverse, large-scale health genomic resources are key to realizing the true potential of research, and to fully exploit the power of new health technologies based on artificial intelligence (AI), to improve health for all.
Chair of CGEn’s Scientific Advisory Board, Dr. Edward M. Rubin has been named a Fellow of the prestigious Royal Society of Canada (RSC) in recognition of his long-term contributions to advancing genomics internationally.
With this renewed support from the Government of Canada through the CFI, CGEn is poised to embark upon the next stage of its strategic vision, continuing to provide the leading genomic infrastructure for Canada’s research and innovation community.